Results 211 to 220 of about 430,745 (290)
Investigation of liver diseases using liver Doppler ultrasound in patients with inflammatory bowel diseases. [PDF]
Shintaku DN +9 more
europepmc +1 more source
Mild phototherapy integrated chemotherapy (mild‐PIC) monitored by real‐time impedance spectroscopy enhances drug efficacy in liver cancer via the “More Light‐Aiding, Less Bonding (LALB)” mechanism, achieving higher targeting with lower toxicity. Abstract Phototherapy integrated chemotherapy (PIC) offers a promising cancer treatment strategy as single ...
Tongge Li +15 more
wiley +1 more source
Lactose intolerance in inflammatory bowel disease [PDF]
Mayur Garg, Peter G. Gibson
openalex +1 more source
Hemophagocytic lymphohistiocytosis in patients with inflammatory bowel diseases: a systematic review. [PDF]
Lan T, Luo Q, Guo X, Jiang X.
europepmc +1 more source
FOXQ1 emerges as a master transcriptional regulator of brain endothelial metabolism, orchestrating mitochondrial function through dual control of calcium signaling and cristae organization. This study reveals that brain endothelial cells rely on oxidative phosphorylation rather than glycolysis alone, challenging the current metabolic paradigm and ...
Wenzheng Zou +8 more
wiley +1 more source
Memory in Misfire: The Gut Microbiome-Trained Immunity Circuit in Inflammatory Bowel Diseases. [PDF]
Yang B, Wu J, Hou X, Bai T, Liu S.
europepmc +1 more source
CellPhenoX is an explainable machine learning framework that identifies cell‐specific phenotypes and interaction effects from single‐cell omics data. By leveraging interpretable models, it enables robust discovery of cell‐level phenotypes that contribute to clinical outcomes.
Jade Young +4 more
wiley +1 more source
The circadian clock, metabolism, and inflammation-the holy trinity of inflammatory bowel diseases. [PDF]
Froy O, Weintraub Y.
europepmc +1 more source
Brain diseases involve multilayered metabolic disruptions that reshape cellular interactions and microenvironments. This review outlines core metabolic features across disease states and presents emerging nanodelivery strategies as precision tools to reprogram pathological metabolism.
Jingyi Zhou, Chen Jiang
wiley +1 more source

